Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 20, 2019 to file lead plaintiff applications in a securities class action lawsuit against Teva Pharmaceutical Industries Limited (NYSE: TEVA), if they purchased the Company’s American Depository Shares (“ADS”) between August 4, 2017 and May 10, 2019, inclusive (the “Class Period”).
June 26, 2019
· 2 min read